Eli Lilly and Company (LLY) Q2 2026 Preview: EPS Est. $6.55, Reports August 5
AlphaStreet Newsdesk powered by AlphaStreet Intelligence Related Coverage LLY|EPS Est $6.55 (21 analysts)|Rev Est $20.69B|Reports 2026-08-05 Midday Wall Street expects ...
Wednesday, August 26, 2026
Tag: Eli
Eli Lilly: Perfektes Pullback-Setup nach Rekordjagd!
Pharmagigant an charttechnischer Schlüsselmarke! Rückblick Nach einer längeren Konsolidierungsphase bis Ende April startete die Aktie einen dynamischen Aufwärtstrend. Eli Lilly ...
Eli Lilly: Pharma-Gigant greift nach der Billionen-Dollar-Krone!
Zwischen astronomischem Wachstum und charttechnischem Momentum! Rückblick Die Story von Eli Lilly lässt sich im Moment in drei Buchstaben zusammenfassen: ...
ZIM CEO Eli Glickman quits over failed bid
Zim Integrated Shipping Services (NYSE: ZIM) CEO and president Eli Glickman has announced that he is stepping down after ...
Jefferies Remains a Buy on Eli Lilly and Company (LLY)
Eli Lilly and Company (NYSE:LLY) is one of the Good Stocks to Buy Now. On March 20, Jefferies reiterated a ...
RBC Capital Initiates Eli Lilly (LLY), Cites Long-Term Leadership in Obesity Market
Eli Lilly and Company (NYSE:LLY) is included among the 14 Best GARP Stocks to Buy According to Analysts. On February ...
Up 36%, Is Eli Lilly Still a Buy?
Eli Lilly is at the forefront of both diabetes and obesity medications. The pharmaceutical giant has offered strong guidance for ...
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.